Dust is depleting snow runoff into the Colorado River, study shows
SALT LAKE CITY () — A study led by University of Utah researchers found that mountain dust is accelerating snowmelt, leading to depleted snowpacks in the Colorado Basin.
'A lot of people assume air temperature is what controls the rate of snowmelt in the Spring, but it's actually the amount of sunlight that's absorbed,' said Professor McKenzie Skiles from the University of Utah.
The on water levels originating from snowmelt in the Upper Colorado River Basin, a region with large amounts of dust that regularly blows onto mountain snowpacks. Researchers say dusty snow absorbs more sunlight, leading to a faster snowmelt.
'That additional energy that's being absorbed accelerates the melt rate,' Skiles told ABC4.com.
According to Skiles, the amount of dust found in Utah snow is largely due to human activity, adding that settlements and widespread grazing have a particularly large impact on dust levels in mountain snow.
South Jordan officials identify firefighter who died after he was found unresponsive on duty
Researchers say current snowmelt models do not account for dust, leading to problems for water managers who rely on forecasts in yearly water allotments. According to Skiles, the time and rate at which snow melts determine our water availability.
Data from the shows 27% of Utahns use Colorado River water, while 60% directly benefit from the river.
Skiles says dust on snow primarily impacts Southern Utah, however, the Wasatch Front's water supply is also affected.
'If we're better able to understand the drivers of dust emission, we could predict how that would impact the snow for the rest of the season,' Skiles said.
Skiles was accompanied by other researchers from the University of Colorado, Boulder, Montana State University, the University of California, Los Angeles, and the University of Utah.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
New paper sheds light on experience of Black prisoners in infamous Stateville prison malaria experiments
Much has been said and written over the years about controversial malaria research conducted on inmates at Illinois' Stateville Penitentiary starting in the 1940s. But at least one part of that story has been largely ignored until now: the role of Black prisoners in that research, which helped lead to the modern practice of using genetic testing to understand how individual patients will react to certain medications, according to the authors of a newly published paper out of the University of Utah. 'We want to highlight the stories of Black prisoners that participated in this prison research in the 1950s onward and give them their due,' said Hannah Allen, a medical ethicist and assistant professor of philosophy at the University of Texas Rio Grande Valley, and first author of the paper, which was published as an opinion piece Wednesday in the Journal of the American Medical Association. 'They haven't been properly acknowledged in the past, and their participation in these studies was really foundational in launching the field of pharmacogenetics and, later on, precision medicine,' said Allen, who recently completed her doctorate at the University of Utah. Starting in the 1940s, researchers infected inmates at the Joliet-area prison with malaria to test the effectiveness of drugs to treat the illness as part of a U.S. military-funded effort to protect American troops overseas, according to the paper. A University of Chicago doctor was the principal investigator. The inmates consented to being part of the studies and were paid for their participation. At first, the research was greeted with enthusiasm. In 1945, Life magazine ran a spread about it, featuring a photo of a Stateville inmate with cups containing malaria-carrying mosquitoes pressed against his bare chest. The first line of the story reads, 'In three U.S. penitentiaries men who have been imprisoned as enemies of society are now helping science fight another enemy of society.' But as the years passed, attitudes began to shift. Questions arose about whether inmates could truly, freely consent to participate in medical experiments or whether they felt coerced into them because of their often dire circumstances. At the Nuremberg trials, defense attorneys for Nazi doctors introduced text and images from the Life article about Stateville prison, though an Illinois physician argued at the trials that the prisoners in Stateville consented to being part of medical research whereas Nazi prisoners did not, according to the JAMA paper. In the mid-1970s, news broke about a study at Tuskegee, in which Black men with syphilis went untreated for years — news that raised awareness of ethical problems in medical research. News outlets also began publishing more stories about prison research, according to the JAMA article. The Chicago Tribune published an article in 1973, in which an inmate participating in the Stateville malaria research said: 'I've been coerced into the project — for the money. Being here has nothing to do with 'doing good for mankind' … I didn't want to keep taking money from my family.' The experiments at Stateville came to a halt in the 1970s. A number of protections and regulations are now in place when it comes to research involving prisoners. Since the 1970s, the Stateville research has often been discussed and analyzed but little attention has been paid to its Black participants, said James Tabery, a medical ethicist and philosophy professor at the University of Utah who led the new research, which was funded by the federal National Institutes of Health. For a time, Black prisoners were excluded from the studies because of a myth that Black people were immune to malaria, Tabery said. Later on, once scientists had pinpointed the drug primaquine as an effective medication for malaria, they turned their attention to the question of why 5% to 10% of Black men experienced a violent reaction to the drug, according to the paper. Ultimately, the scientists were successful, finding that the adverse reaction was related to a specific genetic deficiency. 'There are people all over Chicago today that are getting tested, that clinicians are recommending they get a genetic test before they get prescribed a drug because they want to make sure that their patient isn't going to have an adverse reaction to the drug,' Tabery said. 'It's really sort of powerful and interesting that you can trace that approach to doing good clinical medicine right back to this particular moment and place and population.' But Tabery and Allen also found that the Black prisoners were not treated the same as the white prisoners who participated in research at Stateville. For one, they weren't paid as much as the white prisoners, the rationale being that the white prisoners were infected with malaria, whereas the Black prisoners were given the drug but not infected with the disease — though some of the Black prisoners got very ill after taking the medication, according to the paper. Also, researchers didn't protect the Black participants' privacy as well as they did for other participants. They published certain identifying information about the Black participants, such as initials, ages, heights and weights, whereas participants in the previous research were represented with case numbers, according to the paper. Researchers also recruited the Black prisoners' family members for the study, which they didn't do with earlier participants, according to the paper. 'You see them just doing things with the Black prisoners that they're not doing with the white prisoners,' Tabery said. Also, though scientists made an important discovery through the research on Black prisoners, the episode also highlights the difficulty that can occur in translating discoveries into real life help for patients. Though the World Health Organization now recommends genetic testing to protect people who are sensitive to antimalarials, many of the people who would benefit most from such testing still don't receive it because of financial barriers, supply chain issues and a lack of training, according to the paper. 'What we found is when you sort of shift to what was happening to the Black prisoners, these other lessons you hadn't thought of as being derivable from Stateville suddenly do become apparent,' Tabery said.
Chicago Tribune
4 hours ago
- Chicago Tribune
New paper sheds light on experience of Black prisoners in infamous Stateville prison malaria experiments
Much has been said and written over the years about controversial malaria research conducted on inmates at Illinois' Stateville Penitentiary starting in the 1940s. But at least one part of that story has been largely ignored until now: the role of Black prisoners in that research, which helped lead to the modern practice of using genetic testing to understand how individual patients will react to certain medications, according to the authors of a newly published paper out of the University of Utah. 'We want to highlight the stories of Black prisoners that participated in this prison research in the 1950s onward and give them their due,' said Hannah Allen, a medical ethicist and assistant professor of philosophy at the University of Texas Rio Grande Valley, and first author of the paper, which was published as an opinion piece Wednesday in the Journal of the American Medical Association. 'They haven't been properly acknowledged in the past, and their participation in these studies was really foundational in launching the field of pharmacogenetics and, later on, precision medicine,' said Allen, who recently completed her doctorate at the University of Utah. Starting in the 1940s, researchers infected inmates at the Joliet-area prison with malaria to test the effectiveness of drugs to treat the illness as part of a U.S. military-funded effort to protect American troops overseas, according to the paper. A University of Chicago doctor was the principal investigator. The inmates consented to being part of the studies and were paid for their participation. At first, the research was greeted with enthusiasm. In 1945, Life magazine ran a spread about it, featuring a photo of a Stateville inmate with cups containing malaria-carrying mosquitoes pressed against his bare chest. The first line of the story reads, 'In three U.S. penitentiaries men who have been imprisoned as enemies of society are now helping science fight another enemy of society.' But as the years passed, attitudes began to shift. Questions arose about whether inmates could truly, freely consent to participate in medical experiments or whether they felt coerced into them because of their often dire circumstances. At the Nuremberg trials, defense attorneys for Nazi doctors introduced text and images from the Life article about Stateville prison, though an Illinois physician argued at the trials that the prisoners in Stateville consented to being part of medical research whereas Nazi prisoners did not, according to the JAMA paper. In the mid-1970s, news broke about a study at Tuskegee, in which Black men with syphilis went untreated for years — news that raised awareness of ethical problems in medical research. News outlets also began publishing more stories about prison research, according to the JAMA article. The Chicago Tribune published an article in 1973, in which an inmate participating in the Stateville malaria research said: 'I've been coerced into the project — for the money. Being here has nothing to do with 'doing good for mankind' … I didn't want to keep taking money from my family.' The experiments at Stateville came to a halt in the 1970s. A number of protections and regulations are now in place when it comes to research involving prisoners. Since the 1970s, the Stateville research has often been discussed and analyzed but little attention has been paid to its Black participants, said James Tabery, a medical ethicist and philosophy professor at the University of Utah who led the new research, which was funded by the federal National Institutes of Health. For a time, Black prisoners were excluded from the studies because of a myth that Black people were immune to malaria, Tabery said. Later on, once scientists had pinpointed the drug primaquine as an effective medication for malaria, they turned their attention to the question of why 5% to 10% of Black men experienced a violent reaction to the drug, according to the paper. Ultimately, the scientists were successful, finding that the adverse reaction was related to a specific genetic deficiency. 'There are people all over Chicago today that are getting tested, that clinicians are recommending they get a genetic test before they get prescribed a drug because they want to make sure that their patient isn't going to have an adverse reaction to the drug,' Tabery said. 'It's really sort of powerful and interesting that you can trace that approach to doing good clinical medicine right back to this particular moment and place and population.' But Tabery and Allen also found that the Black prisoners were not treated the same as the white prisoners who participated in research at Stateville. For one, they weren't paid as much as the white prisoners, the rationale being that the white prisoners were infected with malaria, whereas the Black prisoners were given the drug but not infected with the disease — though some of the Black prisoners got very ill after taking the medication, according to the paper. Also, researchers didn't protect the Black participants' privacy as well as they did for other participants. They published certain identifying information about the Black participants, such as initials, ages, heights and weights, whereas participants in the previous research were represented with case numbers, according to the paper. Researchers also recruited the Black prisoners' family members for the study, which they didn't do with earlier participants, according to the paper. 'You see them just doing things with the Black prisoners that they're not doing with the white prisoners,' Tabery said. Also, though scientists made an important discovery through the research on Black prisoners, the episode also highlights the difficulty that can occur in translating discoveries into real life help for patients. Though the World Health Organization now recommends genetic testing to protect people who are sensitive to antimalarials, many of the people who would benefit most from such testing still don't receive it because of financial barriers, supply chain issues and a lack of training, according to the paper. 'What we found is when you sort of shift to what was happening to the Black prisoners, these other lessons you hadn't thought of as being derivable from Stateville suddenly do become apparent,' Tabery said.
Yahoo
10 hours ago
- Yahoo
As Cox advances nuclear agreements, he says the cost to develop technology is nothing so far
Gov. Spencer Cox answers questions from the media during his monthly PBS news conference in Salt Lake City on Tuesday, June 10, 2025. (Pool photo by Bethany Baker/The Salt Lake Tribune) When thinking about Utah's nuclear future, Gov. Spencer Cox said he wants people to think less of the giant nuclear plant where Homer Simpson works, and visualize more a picture of dozens of small modular reactors, stacking in the state over time. While many Utahns are still trying to wrap their heads around the idea Cox is envisioning, he has already signed a couple of memorandums of understanding with companies to help it materialize — and, he said, he wants to go big. On May 23, Cox joined the founder of Valar Atomics, a California nuclear developer, in announcing their partnership to meet President Donald Trump's goal to have an operational advanced reactor on American soil by July 4, 2026, at the San Rafael Energy Research Center in Emery County. SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX On Monday, he signed another agreement with another company for the nuclear efforts, Cox said during his monthly news conference broadcast by PBS Utah. A plan for Utah nuclear energy industry's foundation is taking shape 'We're going to be working with all of these companies. We want to find the best technology. We're not betting on any one technology or any one company. That doesn't make sense,' Cox said on Tuesday. 'We're betting on the idea that there is going to be a nuclear renaissance.' While research shows that nuclear developments usually go for a hefty price tag, Cox said that currently the initial plans won't cost anything to the state, since the state already acquired the San Rafael Energy Lab during the 2024 legislative session and that will be one of the state's main contributions in the agreement. 'We're just providing space for these companies to come in and run their new technology there to see if it actually works,' Cox said. 'And so that's not going to cost us anything. The hope is it will save us down the road.' Lawmakers did agree to fund $10 million for Cox's Operation Gigawatt nuclear initiative; the governor said that money is for siting. Utah has also sought to ease the regulations to make nuclear energy production a reality. First by suing the federal government in January — then still under the Biden administration — over its strict rules to permit the resource. Then, by passing big legislation to set the foundation for the state's nuclear energy future. Glowing pains: Developing nuclear power could cost Utah tens of billions The U.S. is lagging behind countries like China in the development of nuclear plants, Cox said. Now, with a new White House administration prioritizing a quicker licensing process for nuclear reactors and ordering a plan to add 300 gigawatts of nuclear energy capacity in the country by 2050, Cox believes Utah can lead the way. 'The market will decide how big that is,' Cox said, 'government is not going to decide that, but we're going to present opportunities.' Other agreements happening across the state have centered around the construction of power-hungry data and AI centers. While Cox says he remains 'fairly agnostic' on them, he believes they'll be built in many areas of the country either way, drawing a substantial amount of energy from states' shared grid. 'Even if we didn't have a single data center here, we would still need to significantly increase our power production,' Cox said. 'If we're going to significantly increase our power production, we might as well put them here.' SUPPORT: YOU MAKE OUR WORK POSSIBLE
